Expand BMRN Menu
BMRN MENU

BMRN Stock Posts


BMRN Price Trending Down 8 Days in a Row

BMRN Biomarin Pharmaceutical54.75-0.28 (-0.5%)

Biomarin Pharmaceutical has traded lower yet again today, last trading at 54.75. Since this spiral started on 11-Mar-2026, the stock has dropped -10.1% in total. This is the longest downward trend in the last year for BMRN. View Stock Chart
Unusual Option Volume

BMRN Biomarin Pharmaceutical60.19-0.24 (-0.4%)

Biomarin Pharmaceutical trades 1,694 contracts. The highest volume is in the 20-Mar-26 62.5 calls, which is 3.8% above the current price.
View Details...
BMRN #BiomarinPharmaceutical stock declines -3.9% in after hours trading. See the latest news.

After Hours Decliner

BMRN Biomarin Pharmaceutical61.73+0.62+1.0%

After Hours:59.31-2.42 (-3.9%)

U.S. Food and Drug Administration Approves BioMarin's PALYNZIQ (pegvaliase-pqpz) for Adolescents 12 Years of Age and Older with Phenylketonuria (PKU)

PRNewswireFri, 27-Feb 8:00 PM
Unusual Option Volume

BMRN Biomarin Pharmaceutical62.08+0.97 (+1.6%)

Biomarin Pharmaceutical trades 3,135 contracts. The company has the following event: on Feb 28, 2026.
View Details...
Unusual Option Volume

BMRN Biomarin Pharmaceutical62.92-1.16 (-1.8%)

Biomarin Pharmaceutical trades 4,432 contracts. BMRN will report earnings today after the market closes. The company has the following event: on Feb 28, 2026. News: BioMarin Reports Fourth Quarter and Full-year 2025 Financial and Operating Results
View Details...
Upcoming Earnings

BMRN Biomarin Pharmaceutical65.53+1.45 (+2.3%)

Biomarin Pharmaceutical will report earnings after the market closes. View Calendar The market is expecting a ±11.1% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±1.9%. View Expected Move (Conf Call: Feb 23 4:30 PM)
Load Earlier Posts
Market Data Delayed 15 Minutes